2023-07-31 14:51:15 ET
- Rhythm Pharmaceuticals ( NASDAQ: RYTM ) is scheduled to announce Q2 earnings results on Tuesday, August 1st, before market open.
- The consensus EPS Estimate is -$0.78 (+12.4% Y/Y) and the consensus Revenue Estimate is $15.03M (+550.6% Y/Y).
- Over the last 1 year, RYTM has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 3 downward.
For further details see:
Rhythm Pharmaceuticals Q2 2023 Earnings Preview